Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calsun Forte is a high-strength nutritional supplement formulated to support bone health, muscle function, and overall musculoskeletal wellness. Developed by Sunlife Pharmaceuticals, each tablet contains a synergistic combination of elemental calcium (500 mg), elemental magnesium (100 mg), elemental zinc (4 mg), and a high strength of vitamin D3 (cholecalciferol, 500 IU). Calcium serves as the primary structural component of bone, while vitamin D3 enhances its absorption from the gastrointestinal tract. Magnesium plays a critical role in bone mineralization and muscle relaxation, and zinc supports cellular repair, collagen synthesis, and immune function. This combination is typically used to prevent or treat calcium and vitamin D deficiencies, support bone mineral density, and reduce the risk of osteoporosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calsun Forte.